Tuesday, September 9th
Join leading expert Prof. Alazawi for a practical and clinically oriented session designed for physicians managing patients with metabolic liver disease.
He will share his experience on how liver stiffness measurements (LSM by VCTE™) and liver steatosis measurement (Controlled Attenuation Parameter) can guide for effective and confident decisions in the management of MASLD.
• Get a clear overview of Guided VCTE™ and how it enhances FibroScan® performance.
• Learn to interpret key parameters: Liver Stiffness Measurement (LSM), CAP™ (Controlled Attenuation Parameter), with the support of Fast and Agile Scores.
• Review real-world case studies in MASLD/MASH, from diagnosis to follow-up.
• Participate in a live Q&A session with expert answers to your clinical questions.
Take your liver health expertise to the next level. The FibroScan® ecosystem of solutions gives more than a number-it’s a decision-making tool for the future of MASLD care.
Register now
FibroScan®
